According to Agenus
's latest financial reports the company has -$76.77 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $-54.91 M | -214.6% |
2021-12-31 | $47.9 M | -122.65% |
2020-12-31 | $-0.22 B | -8.58% |
2019-12-31 | $-0.24 B | 32.54% |
2018-12-31 | $-0.18 B | 130.22% |
2017-12-31 | $-75.82 M | 93.77% |
2016-12-31 | $-39.13 M | -155.32% |
2015-12-31 | $70.72 M | 207.27% |
2014-12-31 | $23.01 M | -613.68% |
2013-12-31 | $-4.49 M | -74.54% |
2012-12-31 | $-17.6 M | -15.51% |
2011-12-31 | $-20.84 M | 41.64% |
2010-12-31 | $-14.71 M | -13.36% |
2009-12-31 | $-16.98 M | -29.03% |
2008-12-31 | $-23.92 M | -49.18% |
2007-12-31 | $-47.07 M | 170.56% |
2006-12-31 | $-17.4 M | -154.53% |
2005-12-31 | $31.89 M | -70.03% |
2004-12-31 | $0.10 B | 1.14% |
2003-12-31 | $0.10 B | 35.35% |
2002-12-31 | $77.75 M | 2.41% |
2001-12-31 | $75.92 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $70.86 B | -92,424.23% | ๐บ๐ธ USA |
![]() Merck MRK | $46.90 B | -61,205.25% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $32.03 B | -41,826.92% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $15.33 B | -20,081.63% | ๐ฌ๐ง UK |
![]() Celldex Therapeutics CLDX | $0.27 B | -461.56% | ๐บ๐ธ USA |